Patient # | Age | Sex | Site | Campanacci grade | Marginal sclerosis after denosumab | Intralesional matrix sclerosis after denosumab | Pre/post SUV on PET/CT | Time between denosumab and surgery (days) | Follow-up (months) | Local recurrence (time in months) |
---|---|---|---|---|---|---|---|---|---|---|
1 | 19 | Male | Right radius | 2 | Yes | Moderate | 19.5/8.8 | 23 | 47 | No |
2 | 21 | Female | Right radius | 2 | Yes | Mild | 7.2/3.2 | 18 | 17 | No |
3 | 39 | Female | Right ulna | 2 | Yes | Mild | 10.6/2.0 | 36 | 54 | No |
4 | 27 | Female | Left radius | 2 | Yes | Moderate-marked | 17/4.8 | 25 | 35 | No |
5 | 22 | Female | Right radius | 3 | Yes | Moderate-marked | 19.5/4.5 | 39 | 32 | Yes (2) |